The ten companies set to benefit from £15,000 worth of mentoring and coaching at life sciences hub Discovery Park have been revealed.

The Sandwich site has launched its first ever Reactor programme - offering selected firms in the life sciences sphere the opportunity of dedicated guidance on how to grow their business.

Each of the first ten firms selected will undergo eight weeks of guidance using the Triple Chasm Company's 'data-based approach to commercialising innovation'.

Those on the programme include companies developing or delivering clinical diagnostics, drug and medical device discovery, and providing services to biotech and clinical organisations.

The companies selected are: BioMavericks, Clinical Diagnostics, Curtis Analytics, Genestack, MedConcept, Psyros Diagnostics, Scitegrity, SpOtOn, Testavec, VisusNano, and Vitarka Therapeutics.

Dr Martino Picardo, chair of Discovery Park, said: “The UK is home to innovative companies leading the field of life sciences, globally. Accelerating their growth allows the sector, and the wider community, to benefit faster from ground-breaking, innovative healthcare solutions.

"We’re confident that we’ve selected companies with growth potential to be part of the first Reactor programme and we look forward to helping them turn their development plans into positive action.

“The Reactor programme, along with the launch of our new incubator facility in 2022, will go some way to transforming Discovery Park into a world-class hub for the translation of life sciences research, where innovation and collaboration are driving forward the next generation of healthcare initiatives and discoveries.”

Discovery Park was previously owned by drug giant Pfizer before its decision in 2011 to dramatically downscale, leading to the loss of more than 2,000 jobs.

Pfizer retains the largest presence on the site - employing more than 700 staff - which it now shares with more than 160 science-based firms.

Head to our business page for all of the latest news about businesses in Kent